Company: LHI
Filing Date: 2025-08-08
Form Type: F-1/A
Source: 0001213900-25-073646
Chunk: 217

Company: Living Homeopathy International Ltd.
Filing Date: 2025-08-08
Form: F-1/A
Chunk 217
---
 equal
to 1.0% of the gross proceeds raised in this offering.

Lock-Up Agreements

We agreed that, subject to certain exceptions set forth in the underwriting
agreement/lock-up agreements, we will not, without the prior written consent of the Representative, from the date of execution of the
underwriting agreement and continuing for six (6) months from the closing date of this offering, (i) offer, sell, or otherwise
transfer or dispose of, directly or indirectly, any Class A Ordinary Shares of the Company or any securities convertible into or exercisable
or exchangeable for Class A Ordinary Shares of the Company; or (ii) file or caused to be filed any registration statement with the SEC
relating to the offering of any Class A Ordinary Shares of the Company or any securities convertible into or exercisable or exchangeable
for Class A Ordinary Shares of the Company.

Each of our officers, directors, and all existing shareholders who own
5% or more of the issued and outstanding Class A Ordinary Shares after this Offering agree not to offer, issue, sell, contract to sell,
encumber, grant any option for the sale of or otherwise dispose of any Class A Ordinary Shares or other securities convertible into or
exercisable or exchangeable for Class A Ordinary Shares for up to six (6) months from the closing date of this offering, without
the prior written consent of the Representative.

The Representative may in its sole discretion
and at any time without notice release some or all of the shares subject to lock-up agreements prior to the expiration of the lock-up
period. When determining whether or not to release shares from the lock-up agreements, the Representative will consider, among other factors,
the security holder’s reasons for requesting the release, the number of shares for which the release is being requested and market
conditions at the time.

Application for Nasdaq Listing

We applied to have our Class A Ordinary Shares approved for listing/quotation on the Nasdaq Capital Market under the symbol “LHI.” We will not consummate and close this Offering without a listing approval letter from the Nasdaq Capital Market. Our receipt of a listing approval letter is not the same as an actual listing on the Nasdaq Capital Market. The listing approval letter will serve only to confirm that, if we sell a number of Class A Ordinary Shares in this Offering sufficient to satisfy applicable listing criteria, our Class A Ordinary Shares will in fact be listed.

If the application is approved, trading of our
Class A Ordinary Shares on